141
Views
77
CrossRef citations to date
0
Altmetric
Original Article

Fish Oil Supplementation in Pregnancy Lowers F2-isoprostanes in Neonates at High Risk of Atopy

, , , , , , & show all
Pages 233-239 | Received 22 Oct 2003, Published online: 07 Jul 2009

References

  • Bowler, R.P. and Crapo, J.D. (2002) "Oxidative stress in allergic respiratory diseases", J. Allergy Clin. Immunol. 110, 349–356.
  • Shanmugasundaram, K.R., Kumar, S.S. and Rajajee, S. (2001) "Excessive free radical generation in the blood of children suffering from asthma", Clin. Chim. Acta 305, 107–114.
  • Romagnani, S. (1991) "Human TH1 and TH2 subsets: doubt no more", Immunol. Today 12, 256–257.
  • Utsugi, M., Dobashi, K., Koga, Y, Shimizu, Y, Ishizuka, T., lizuka, K., Hamuro, J., Nakazawa, T. and Mori, M. (2002) "Glutathione redox regulates lipopolysaccharide-induced IL-12 production through p38 mitogen-activated protein kinase activation in human monocytes: role of glutathione redox in UN-gamma priming of IL-12 production", J. Leukoc. Biol. 71, 339–347.
  • Murata, Y, Shimamura, T. and Hamuro, J. (2002) "The polarization of T(h)1 /T(h)2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine production", Int. Immunol. 14, 201–212.
  • Roberts, L.J. and Morrow, J.D. (2000) "Measurement of F2 isoprostanes as an index of oxidative stress in vivo", Free Radic. Biol. Med. 28, 505–513.
  • Wood, L.G., Fitzgerald, D.A., Gibson, P.G., Cooper, D.M. and Garg, M.L. (2000) "Lipid permddation as determined by plasma isoprostanes is related to disease severity in mild asthma", Lipids 35, 967–974.
  • Montuschi, P., Corradi, M., Ciabattoni, G., Nightingale, J., Kharitonov, S.A. and Barnes, P.J. (1999) "Increased 8-isoprostane, a marker of oxidative stress in exhaled condensate of asthmatic patients", Am. J. Respir. Crit. Care Med. 160, 216–220.
  • Calder, P.C. (2001) "N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?", Nutr. Res. 21, 309–341.
  • Mori, T.A., Dunstan, D.W., Burke, V, Croft, K.D., Rivera, J.H., Beilin, L.J. and Puddey, I.B. (1999) "Effects of dietary fish and exercise training on urinary F2-Isoprostane excretion in non-insulin dependent diabetic patients", Metabolism 48, 1402–1408.
  • Mori, T.A., Puddey, I.B., Burke, V, Croft, K.D., Dunstan, D.W., Rivera, J.H. and Beilin, L.J. (2000) "Effect of co3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion", Redox Rep. 5, 45–46.
  • Mori, T.A., Woodman, R.J., Burke, V, Puddey, I.B., Croft, K.D. and Beilin, L.J. (2003) "Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers, in treated-hypertensive Type 2 diabetic subjects", Free Radic. Biol. Med., in press.
  • Duchen, K., Yu, G. and Bjorksten, B. (1998) "Atopic sensitisation during the first year of life in relation to long chain polyunsaturated fatty acid levels in human milk", Pediatr. Res. 44, 478–484.
  • Dunstan, J.A., Mori, T.A., Barden, A., Beilin, L.J., Taylor, A.L., Holt, P.G. and Prescott, S.L. (2003) "Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy", Clin. Exp. Allergy 33, 442–448.
  • Mori, T.A., Croft, K.D., Puddey, I.B. and Beilin, L.J. (1999) "An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography—mass spectrometry", Anal. Biochem. 268, 117–125.
  • Mori, T.A., Burke, V, Puddey, I.B., Watts, GE, O'Neal, D.N., Best, J.D. and Beilin, L.J. (2000) "Purified eicosapentaenoic acid and docosahexaenoic acid have differential effects on serum lipids and lipoproteins, LDL—particle size, glucose and insulin, in mildly hyperlipidemic men", Am. J. Clin. Nutr. 71, 1085–1094.
  • Ng, T.W., Holt, P.G. and Prescott, S.L. (2002) "Cellular immune responses to ovalbumin and house dust mite in egg allergic children", Allergy 57, 207–214.
  • Prescott, S.L., Taylor, A., King, B., et al. (2003) "Neonatal interleukin-12 capacity is associated with variations in allergen-specific immune responses in the neonatal and postnatal periods", Clin. Exp. Allergy 33, 566–572.
  • Stier, C., Scheer, H., Jelinek, J., Watzer, B., Seyberth, H.W. and Leonhardt, A. (2001) "Effect of preterm formula with and without long-chain polyunsaturated fatty acids on the urinary excretion of F2-isoprostanes and 8-epi- prostaglandin F2e,", J. Pediatr. Gastroenterol. Nutr. 32, 137–141.
  • Barden, A.E., Ritchie, J., Walters, B., Michael, C., Rivera, J., Mori, T., Croft, K. and Beilin, L.J. (2001) "A study of plasma factors associated with neutrophil activation and lipid peroxidation in pre-eclampsia", Hypertension 38, 803–808.
  • Berger, T.M., Polidori, M.C., Dabbagh, A., Evans, P.J., Halliwell, B., Morrow, J.D., Roberts, L.J., II and Frei, B. (1997) "Antioxidant activity of vitamin C in iron-overloaded human plasma", J. Biol. Chem. 272, 15656–15660.
  • Qin, Y, Wang, C.C., Kuhn, H., Rathmann, J., Pang, CE and Rogers, US. (2000) "Determinants of umbilical cord arterial 8-iso-prostaglandin F2,,, concentrations", Br. J. Obstet. Gynecol. 107, 973–981.
  • Frank, L. and Sosenko, R.S. (1987) "Development of lung anti-oxidant enzyme systems in late gestation: possible implications for the prematurely born infant", J. Pediatr. 110, 9–14.
  • Evans, P.J., Evans, R., Kovar, I.Z., Holton, A.F. and Halliwell, B. (1992) "Bleomycin-detectable iron in the plasma of premature and full-term neonates", FEBS Lett. 303, 210–212.
  • Buonocore, G., Perrone, S., Longing, M., et al. (2002) "Oxidative stress in pretem infants at birth and on the seventh day of life", Pediatr. Res. 52, 46–49.
  • Quaggiotto, P, Leitch, J.W., Falconer, J., Murdoch, R.N. and Garg, M.L. (2000) "Plasma F2-isoprostane levels are lowered in pigs fed an (n-3) polyunsaturated fatty acid supplemented diet following occlusion of the left anterior descending coronary artery", Nutr. Res. 20, 675–684.
  • Higdon, J.V., Liu, J.K., Du, S.H., Morrow, J.D., Ames, B.N. and Wander, R.C. (2000) "Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F2-isoprostanes", Am. J. Clin. Nutr. 72, 714–722.
  • Coleman, R. (1986) "Placental metabolism and transport of lipid", Federation Proc. 45, 2519–2523.
  • Nourooz-Zadeh, J., Halliwell, B. and Anggard, E.E. (1997) "Evidence for the formation of Frisoprostanes during permddation of eicosapentaenoic acid", Biochem. Biophys. Res. Commun. 236, 467–472.
  • Nourooz-Zadeh, J., Lui, E.H.C., Yhlen, B., Anggard, E.E. and Halliwell, B. (1999) "F4-isoprostanes as specific marker of docosahexaenoic acid permddation in Alzheimer's disease", J. Neurochem. 72, 734–740.
  • Roberts, J.L., Montine, T.J., Markesbery, W.R., Tapper, A.R., Hardy, P., Chemtob, S., Dettbarn, W.D. and Morrow, J.D. (1998) "Formation of Isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid", J. Biol. Chem. 273, 13605–13612.
  • Khair, E.R., Din, T.A., Sicher, S.C., Vazquez, M.A., et al. (1995) "Docosahexaenoic acid, a major consituent of fetal serum and fish oil diets, inhibits IFN'y induced Ia expression by murine macrophages in vitro", J. Immunol. 154, 1296–1306.
  • Hughes, D.A., Pinder, A.C., Piper, Z., Johnson, IT. and Lund, E.K. (1996) "Fish oil supplementation inhibits expression of major histocompatibility complex Class II molecules and adhesion on human monocytes", Am. J. Clin. Nutr. 63, 267–272.
  • Sampson, M.J., Davies, I.R., Brown, J.C., Morgan, V, Richardson, T., James, A.J., Sampson, A.P. and Hughes, D.A. (2001) "N-3 polyunsaturated fatty acid supplemen-tation, monocyte adhesion molecule expression and pro-inflammatory mediators in Type 2 diabetes mellitus", Diabetic Med. 18, 51–58.
  • Grimm, M., Speicker, M., De Caterina, R., Shin, W.S. and Liao, J.K. (2002) "Inhibition of major histocompatibility complex class II gene transcription by nitric oxide and antioxidants", J. Biol. Chem. 277, 26460–26467.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.